Norma Peter

4.5k total citations · 1 hit paper
13 papers, 1.7k citations indexed

About

Norma Peter is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Norma Peter has authored 13 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 4 papers in Genetics. Recurrent topics in Norma Peter's work include Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Norma Peter is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Norma Peter collaborates with scholars based in Germany, Switzerland and Netherlands. Norma Peter's co-authors include Michael Pfreundschuh, Bernd Metzner, Marcel Reiser, Lorenz Trümper, Hermann Einsele, Eva Hoster, Martin Dreyling, Wolfgang Hiddemann, Michael Unterhalt and Bernhard Wörmann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Norma Peter

13 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

2007 621 citations Eva Hoster, Martin Dreyling et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Norma Peter Germany	9	1.5k	1.0k	562	262	259	13	1.7k
José Rodríguez Spain	24	1.7k 1.1×	1.2k 1.1×	543 1.0×	201 0.8×	317 1.2×	64	2.1k
Patricia Aoun United States	22	1.4k 0.9×	885 0.9×	635 1.1×	175 0.7×	293 1.1×	48	1.8k
Roswitha Forstpointner Germany	15	1.5k 1.0×	1.1k 1.1×	732 1.3×	235 0.9×	188 0.7×	38	1.7k
Liliana Devizzi Italy	22	1.5k 1.0×	960 0.9×	478 0.9×	376 1.4×	456 1.8×	59	1.9k
Annarita Conconi Italy	24	1.9k 1.2×	1.0k 1.0×	701 1.2×	386 1.5×	550 2.1×	71	2.3k
Gerardo Musuraca Italy	20	1.2k 0.8×	559 0.5×	532 0.9×	292 1.1×	304 1.2×	83	1.7k
Alessandro Broccoli Italy	22	1.2k 0.8×	631 0.6×	326 0.6×	262 1.0×	375 1.4×	116	1.6k
Krimo Bouabdallah France	22	1.4k 1.0×	1.1k 1.1×	798 1.4×	191 0.7×	320 1.2×	119	2.1k
M. Dreyling Germany	16	1.2k 0.8×	773 0.7×	438 0.8×	182 0.7×	261 1.0×	22	1.3k
C. Portlock United States	21	1.1k 0.7×	732 0.7×	438 0.8×	367 1.4×	261 1.0×	36	1.6k

Countries citing papers authored by Norma Peter

Since Specialization

Citations

This map shows the geographic impact of Norma Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Peter more than expected).

Fields of papers citing papers by Norma Peter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norma Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Peter. The network helps show where Norma Peter may publish in the future.

Co-authorship network of co-authors of Norma Peter

This figure shows the co-authorship network connecting the top 25 collaborators of Norma Peter. A scholar is included among the top collaborators of Norma Peter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norma Peter. Norma Peter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Niederwieser, Dietger, Haifa Kathrin Al‐Ali, Rainer Krahl, et al.. (2016). Hematopoietic stem cell transplantation (HSCT) compared to consolidation chemotherapy (CT) to increase leukemia free survival (LFS) in acute myelogenous leukemia (AML) patients between 60 and 75 years irrespective of genetic risk: Report from the AML 2004 of the East German Study Group (OSHO).. Journal of Clinical Oncology. 34(15_suppl). e18501–e18501. 4 indexed citations

Elias, K., Axel Benner, Uta Bertsch, et al.. (2016). Single versus tandem high‐dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long‐term results from the phase III GMMG‐HD2 trial. British Journal of Haematology. 173(5). 731–741. 47 indexed citations

Flohr, Thomas, Norbert Frickhofen, Martin Gramatzki, et al.. (2014). Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study. British Journal of Haematology. 168(6). 824–834. 10 indexed citations

Hoster, Eva, Michael Unterhalt, Michael Pfreundschuh, et al.. (2014). The Addition of Rituximab to CHOP Improves Failure-Free and Overall Survival of Mantle-Cell Lymphoma Patients – a Pooled Trials Analysis of the German Low-Grade Lymphoma Study Group (GLSG). Blood. 124(21). 1752–1752. 5 indexed citations

Schmitz, Norbert, Maike Nickelsen, Marita Ziepert, et al.. (2012). Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1). The Lancet Oncology. 13(12). 1250–1259. 152 indexed citations

Müller, Carsten, Niels Murawski, Martin H. J. Wiesen, et al.. (2012). The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL. Blood. 119(14). 3276–3284. 186 indexed citations

Niederwieser, Dietger, Leo F. Verdonck, Jan J. Cornelissen, et al.. (2011). Long Term Outcome After Low Dose TBI Based Conditioning Hematopoietic Stem Cell Transplantation (HSCT) From Related and Unrelated Donors for Older Patients with AML. Blood. 118(21). 2030–2030. 1 indexed citations

Schmitz, Norbert, Lorenz Trümper, Marita Ziepert, et al.. (2010). Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood. 116(18). 3418–3425. 377 indexed citations

Zwick, Carsten, Josef Birkmann, Norma Peter, et al.. (2008). Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone). Annals of Hematology. 87(9). 717–726. 5 indexed citations

10.

Hoster, Eva, Thomas Zwingers, Günter Brittinger, et al.. (2008). Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma. Journal of Clinical Oncology. 27(4). 511–518. 291 indexed citations

11.

Hoster, Eva, Martin Dreyling, Wolfram Klapper, et al.. (2007). A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 111(2). 558–565. 621 indexed citations breakdown →

12.

Poeschel, Viola, Maike Nickelsen, Mathias Hänel, et al.. (2006). Dose-Dense Rituximab in Combination with Biweekly CHOP-14 for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of a Phase-I/II and Pharmacokinetic Study of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).. Blood. 108(11). 2738–2738. 8 indexed citations

13.

Glossmann, Jan‐Peter, Jan Oliver Staak, Lucia Nogová, et al.. (2005). Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma. Annals of Hematology. 84(8). 517–525. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact